https://www.fiercepharma.com/pharma/astrazeneca-first-look-imfinzi-resectable-lung-cancer-data-fueling-treatment-debate
0
0
AACR: AstraZeneca's Imfinzi lung cancer data raise new questions - FiercePharma
4/16/23 at 3:00pm
Organization
FiercePharma
Author
FiercePharma
11 words
0
Comments
You are the first to view
Create an account or login to join the discussion